-
Patient Prefer Adher · Jan 2024
Case ReportsReal-Time Experience of Abrocitinib for the Treatment of Mucous Membrane Pemphigoid: A Case Report.
- Yan Teng, Mingyang Ren, Xianhong Yang, Wei Lu, and Xiaohua Tao.
- Center for Plastic & Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital of Hangzhou Medical College, Hangzhou, 310014, People's Republic of China.
- Patient Prefer Adher. 2024 Jan 1; 18: 503506503-506.
BackgroundMucous membrane pemphigoid (MMP), a rare autoimmune vesiculous and erosive disorder, may affect multiple mucous membranes, with the oral cavity being the most commonly affected site. Its treatment depends on the site(s) of mucosal involvement and disease severity.Patients And MethodsA 62-year-old female patient with MMP that predominantly involved the oral cavity strongly rejected systemic corticosteroid or immunosuppressive agents and was successfully treated with abrocitinib, a highly selective JAK-1 inhibitor with a good safety profile.ResultsThe case demonstrated good efficacy and safety profile of abrocitinib for the treatment of MMP with predominant oral involvement.ConclusionAbrocitinib is a promising agent for the treatment of MMP with oral involvement.© 2024 Teng et al.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.